vs
Side-by-side financial comparison of GE HealthCare (GEHC) and Hartford (The) (HIG). Click either name above to swap in a different company.
GE HealthCare is the larger business by last-quarter revenue ($5.7B vs $4.1B, roughly 1.4× Hartford (The)). Hartford (The) runs the higher net margin — 13.2% vs 10.3%, a 2.9% gap on every dollar of revenue. On growth, GE HealthCare posted the faster year-over-year revenue change (7.1% vs -43.7%). Over the past eight quarters, GE HealthCare's revenue compounded faster (10.7% CAGR vs -20.8%).
GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures...
The Hartford Insurance Group, Inc., known as The Hartford, is a U.S.-based insurance company. The Hartford is a Fortune 500 company headquartered in its namesake city of Hartford, Connecticut. It was ranked 162nd in Fortune 500 in 2024. The Hartford is a leader in property and casualty insurance, employee benefits and mutual funds. With more than 200 years of expertise, The Hartford is widely recognized for its service excellence, sustainability practices, trust and integrity. It sells produc...
GEHC vs HIG — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $5.7B | $4.1B |
| Net Profit | $588.0M | $536.0M |
| Gross Margin | 39.7% | — |
| Operating Margin | 14.5% | — |
| Net Margin | 10.3% | 13.2% |
| Revenue YoY | 7.1% | -43.7% |
| Net Profit YoY | -18.4% | 12.0% |
| EPS (diluted) | $1.28 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $4.1B | ||
| Q4 25 | $5.7B | $7.3B | ||
| Q3 25 | $5.1B | $7.2B | ||
| Q2 25 | $5.0B | $7.0B | ||
| Q1 25 | $4.8B | $6.8B | ||
| Q4 24 | $5.3B | $6.9B | ||
| Q3 24 | $4.9B | $6.8B | ||
| Q2 24 | $4.8B | $6.5B |
| Q1 26 | — | $536.0M | ||
| Q4 25 | $588.0M | — | ||
| Q3 25 | $446.0M | $1.1B | ||
| Q2 25 | $486.0M | $995.0M | ||
| Q1 25 | $564.0M | $630.0M | ||
| Q4 24 | $721.0M | — | ||
| Q3 24 | $470.0M | $767.0M | ||
| Q2 24 | $428.0M | $738.0M |
| Q1 26 | — | — | ||
| Q4 25 | 39.7% | — | ||
| Q3 25 | 38.7% | — | ||
| Q2 25 | 39.6% | — | ||
| Q1 25 | 42.1% | — | ||
| Q4 24 | 42.8% | — | ||
| Q3 24 | 41.7% | — | ||
| Q2 24 | 41.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | 14.5% | 19.3% | ||
| Q3 25 | 12.7% | 18.2% | ||
| Q2 25 | 13.1% | 17.8% | ||
| Q1 25 | 13.2% | 11.5% | ||
| Q4 24 | 15.1% | 15.6% | ||
| Q3 24 | 13.9% | 14.1% | ||
| Q2 24 | 12.6% | 14.1% |
| Q1 26 | — | 13.2% | ||
| Q4 25 | 10.3% | — | ||
| Q3 25 | 8.7% | 14.9% | ||
| Q2 25 | 9.7% | 14.2% | ||
| Q1 25 | 11.8% | 9.3% | ||
| Q4 24 | 13.6% | — | ||
| Q3 24 | 9.7% | 11.4% | ||
| Q2 24 | 8.8% | 11.4% |
| Q1 26 | — | — | ||
| Q4 25 | $1.28 | $3.96 | ||
| Q3 25 | $0.98 | $3.77 | ||
| Q2 25 | $1.06 | $3.44 | ||
| Q1 25 | $1.23 | $2.15 | ||
| Q4 24 | $1.58 | $2.88 | ||
| Q3 24 | $1.02 | $2.56 | ||
| Q2 24 | $0.93 | $2.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.5B | $1.7M |
| Total DebtLower is stronger | $10.0B | — |
| Stockholders' EquityBook value | $10.4B | $16.8M |
| Total Assets | $36.9B | $86.3M |
| Debt / EquityLower = less leverage | 0.96× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $1.7M | ||
| Q4 25 | $4.5B | — | ||
| Q3 25 | $4.0B | — | ||
| Q2 25 | $3.7B | — | ||
| Q1 25 | $2.5B | — | ||
| Q4 24 | $2.9B | — | ||
| Q3 24 | $3.5B | — | ||
| Q2 24 | $2.0B | — |
| Q1 26 | — | — | ||
| Q4 25 | $10.0B | $4.4B | ||
| Q3 25 | $10.3B | $4.4B | ||
| Q2 25 | $10.3B | $4.4B | ||
| Q1 25 | $8.8B | $4.4B | ||
| Q4 24 | $9.0B | $4.4B | ||
| Q3 24 | $10.3B | $4.4B | ||
| Q2 24 | $9.2B | $4.4B |
| Q1 26 | — | $16.8M | ||
| Q4 25 | $10.4B | $19.0B | ||
| Q3 25 | $10.0B | $18.4B | ||
| Q2 25 | $9.7B | $17.5B | ||
| Q1 25 | $9.2B | $16.8B | ||
| Q4 24 | $8.4B | $16.4B | ||
| Q3 24 | $8.3B | $17.0B | ||
| Q2 24 | $7.8B | $15.7B |
| Q1 26 | — | $86.3M | ||
| Q4 25 | $36.9B | $86.0B | ||
| Q3 25 | $36.1B | $85.0B | ||
| Q2 25 | $35.5B | $83.6B | ||
| Q1 25 | $33.6B | $82.3B | ||
| Q4 24 | $33.1B | $80.9B | ||
| Q3 24 | $33.9B | $81.2B | ||
| Q2 24 | $31.9B | $79.0B |
| Q1 26 | — | — | ||
| Q4 25 | 0.96× | 0.23× | ||
| Q3 25 | 1.03× | 0.24× | ||
| Q2 25 | 1.06× | 0.25× | ||
| Q1 25 | 0.95× | 0.26× | ||
| Q4 24 | 1.06× | 0.27× | ||
| Q3 24 | 1.24× | 0.26× | ||
| Q2 24 | 1.18× | 0.28× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GEHC
| Imaging Segment | $2.6B | 45% |
| PCS Segment | $824.0M | 14% |
| P Dx Segment | $790.0M | 14% |
| Specialized Ultrasound Subsegment | $735.0M | 13% |
| Monitoring Solutions Subsegment | $578.0M | 10% |
| Life Support Solutions Subsegment | $247.0M | 4% |
HIG
| Earned premiums | $3.6B | 88% |
| Other | $486.0M | 12% |
| Fee income | $12.0M | 0% |
